Wall Street Cuts Mosaic Again: UBS Slashes Target to $27
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Quick take on safety: bonds vs cash in retirement, highlighting scenarios where each preserves capital and meets withdrawal needs.
24,731 articlesUBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
A high-profile insider purchase is drawing attention as American Assets Trust trades near an 18-month high. Discover ...
Investing in AI requires more than hype. This guide explains how a Nvidia-backed infrastructure stock hand can unlock...
A 137-year-old spice company bets on a broader food portfolio with Unilever’s iconic brands. This deep dive explains ...
As spacemobile nears commercial launch, investors wonder if this space-based cellular plan can disrupt the market. Th...
This in-depth guide analyzes agilon health (agl) 2025 implications for investors. Learn the business model, key metri...
As Rivian pivots toward the R2 and scalable production, investors wonder if the company can disrupt market reward in ...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Tech shares wobble as regulatory headlines hit the tape. This piece breaks down the Snap slump, regulatory risks from...